These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19525311)

  • 21. NICE proposes to withdraw Alzheimer's drugs from NHS.
    Kmietowicz Z
    BMJ; 2005 Mar; 330(7490):495. PubMed ID: 15746112
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer).
    Tifratene K; Duff FL; Pradier C; Quetel J; Lafay P; Schück S; Benzenine E; Quantin C; Robert P
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):1005-12. PubMed ID: 22718684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Not so NICE. A proposal from the National Institute for Clinical Excellence to withdraw treatments for Alzheimer's disease from the NHS has left support groups reeling.
    Heath H
    Nurs Older People; 2005 Apr; 17(2):8. PubMed ID: 15835500
    [No Abstract]   [Full Text] [Related]  

  • 24. Guidelines on drug treatments for Alzheimer's disease.
    Lovestone S; Graham N; Howard R
    Lancet; 1997 Jul; 350(9073):232-3. PubMed ID: 9242796
    [No Abstract]   [Full Text] [Related]  

  • 25. Issues in drug treatment for Alzheimer's disease.
    McShane R; Keene J; Fairburn C; Jacoby R; Hope T
    Lancet; 1997 Sep; 350(9081):886-7. PubMed ID: 9310624
    [No Abstract]   [Full Text] [Related]  

  • 26. New US guidelines for Alzheimer's disease released.
    Larkin M
    Lancet; 2001 May; 357(9267):1505. PubMed ID: 11377609
    [No Abstract]   [Full Text] [Related]  

  • 27. Medicinal products in the treatment of Alzheimer's disease.
    Eur Neuropsychopharmacol; 1998 Aug; 8(3):241-5. PubMed ID: 9716320
    [No Abstract]   [Full Text] [Related]  

  • 28. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review].
    Strnad J; Bahro M
    Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539
    [No Abstract]   [Full Text] [Related]  

  • 29. New drug treatment for Alzheimer's disease. SMAC's advice on use of donepezil is contradictory.
    Baxter T; Black D; Prempeh H
    BMJ; 1998 Oct; 317(7163):946. PubMed ID: 9841011
    [No Abstract]   [Full Text] [Related]  

  • 30. Drugs for Alzheimer's disease. Guidelines for prescribing cholinesterase inhibitors in Australia are similar to those in UK.
    Noble JM
    BMJ; 2001 Nov; 323(7321):1128. PubMed ID: 11725756
    [No Abstract]   [Full Text] [Related]  

  • 31. Raw deal for dementia patients in the UK.
    Lancet Neurol; 2007 Oct; 6(10):839. PubMed ID: 17884665
    [No Abstract]   [Full Text] [Related]  

  • 32. Introduction. Alzheimer's disease: from research to practice.
    Schneider LS
    J Clin Psychiatry; 1998; 59 Suppl 11():3. PubMed ID: 9731542
    [No Abstract]   [Full Text] [Related]  

  • 33. People with Alzheimer's disease are denied drugs.
    Scott H
    Br J Nurs; 2000 Nov 9-22; 9(20):2120. PubMed ID: 12271179
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug treatment for Alzheimer's disease: the way forward.
    Maidment I; Fox C; Livingston G; Katona C
    Int J Geriatr Psychiatry; 2006 Jan; 21(1):6-8. PubMed ID: 16353163
    [No Abstract]   [Full Text] [Related]  

  • 35. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias.
    Ihl R; Frölich L; Winblad B; Schneider L; Burns A; Möller HJ;
    World J Biol Psychiatry; 2011 Feb; 12(1):2-32. PubMed ID: 21288069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Issues in drug treatment for Alzheimer's disease.
    Kellett JM
    Lancet; 1997 Sep; 350(9081):887. PubMed ID: 9310626
    [No Abstract]   [Full Text] [Related]  

  • 37. Issues in drug treatment for Alzheimer's disease.
    Mackay AV
    Lancet; 1997 Sep; 350(9081):887. PubMed ID: 9310625
    [No Abstract]   [Full Text] [Related]  

  • 38. Effectiveness of rivastigmine in Alzheimer's disease. Guidelines do not ignore clinically relevant end points.
    Storosum JG; van Zwieten-Boot BJ; Elferink AJ
    BMJ; 1999 Sep; 319(7210):642. PubMed ID: 10523096
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of Alzheimer's disease.
    Browning CH
    Am J Psychiatry; 1998 Oct; 155(10):1460-1. PubMed ID: 9766786
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rational pharmaco-therapeutic algorithms for the management of Alzheimer's disease].
    Belousov IuB; Danilov AN; Zyrianov SK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):59-64. PubMed ID: 21465821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.